Lynx Biosciences Closes Series Seed Equity Round Led by Checkmate Capital Group
03 nov. 2021 10h00 HE
|
Lynx Biosciences, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Lynx Biosciences, Inc. ("LynxBio®"), a San Diego-based biotechnology company, today announced the successful closing of its Series Seed Preferred Stock...